To view this page ensure that Adobe Flash Player version
11.1.0 or greater is installed.
Are You Ready? Patient Empowerment is Here to Stay By Eric Racine, Pharm.D, MBA Vice President Global Patient Advocacy Sanofi Marcia Horn, JD President & Chief Executive Officer International Cancer Advocacy Network (ICAN) DIA Global Forum Content Co-Editors for Patients There is energy behind “patient empowerment” and related concepts that are fast becoming the new norm for the biopharmaceutical industry and many other stakeholders involved in health care. Several terms are used to describe this movement, and for organizations that are truly changing their focus on patients, important distinctions in terminology are worth noting: • Patient engagement—Bringing patients to the table and involving them in meaningful ways • Patient empowerment—Helping patients set and drive the agenda in matters affecting their health • Patient centricity—Putting patients at the center of everything we do Each of these terms reflects the reality that the different stakeholders throughout the health care 30 Vol 7 Issue 2 ecosystem—the innovators, providers, payers, regulators, and policy makers—are aiming to be closer to the person they all serve: the patient. Enhanced patient engagement leads to better medical solutions, improved patient outcomes, and lower costs for health care delivery systems. Judith Hibbard, from the University of Oregon, found that patients with lower “activation” were associated with higher costs. The Patient Activation Measure (PAM) categorizes patients into four levels of increasing engagement: 1. Believing the patient role is important 2. Having the confidence and knowledge necessary to take action 3. Actually taking action to maintain and improve one’s health; and